Trials / Unknown
UnknownNCT04194723
Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux
Phase II Clinical Study on the Safety and Efficacy of Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II clinical study to investigate the safety and efficacy of endoscopic antireflux mucosectomy (ARMS) for treatment of GERD.
Detailed description
The objective of the study is to establish the clinical efficacy and safety of ARMS for treatment of GERD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Antireflux Mucosectomy | ARMS aimed at resection of mucosa at gastric cardia to induce fibrosis and tighten the gastroesophageal junction and reduce acid reflux |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2019-12-11
- Last updated
- 2023-11-07
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04194723. Inclusion in this directory is not an endorsement.